Company profile · Goettingen, Germany

Sartorius

Bioprocess Systems and Single-use Manufacturing Technology · Global bioprocess infrastructure

GermanyToolsGoettingen

Bioprocess infrastructure backbone with ISO 7/8 cleanroom production, single-use systems, and installed equipment across Baltic biologics manufacturing.

Lead
Michael Grosse (verified ↗)
Address
Otto-Brenner-Strasse 20, 37079 Goettingen, Germany (source ↗)
Compliance
ISO 9001 · ISO 13485 · ISO 14001 · ISO 50001
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Global bioprocess infrastructure
Capabilities
Single-use Bioprocess Equipment · Cell Culture Media · Process Analytics
Founded
1870
Headcount
10000+
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Michael Grosse

Chief Executive Officer

Check official leadership source
Full addressOtto-Brenner-Strasse 20, 37079 Goettingen, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official Sartorius terms and privacy pages naming the Goettingen campus at Otto-Brenner-Strasse 20.

Open source
Operating profile

Global bioprocess infrastructure

Goettingen, Germany. Bioprocess Systems and Single-use Manufacturing Technology. Review completed on 14 Mar 2026.

2026 technical specializationBioprocess Systems and Single-use Manufacturing Technology
Core capabilities
Single-use Bioprocess EquipmentCell Culture MediaProcess Analytics
Governance

European life science and bioprocess quality frameworks

ISO 9001, ISO 13485, ISO 14001, ISO 50001

Editorial note

Bioprocess Systems and Single-use Manufacturing Technology

Bioprocess infrastructure backbone with ISO 7/8 cleanroom production, single-use systems, and installed equipment across Baltic biologics manufacturing.

Editorial note

Michael Grosse entered the CEO role on 1 July 2025, giving the registry a current official leadership basis for the 2026 German infrastructure layer.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Single-use Bioprocess Equipment
Cell Culture Media
Process Analytics
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceSartorius AG announcement appointing Michael Grosse as CEO effective 1 July 2025.Source origin: sartorius.comOpen source
Supporting evidenceSartorius executive committee page.Source origin: sartorius.comOpen source
Physical-site evidenceOfficial Sartorius terms and privacy pages naming the Goettingen campus at Otto-Brenner-Strasse 20.Source origin: sartorius.comOpen source
Infrastructure

Declared infrastructure

BIOSTAT STR systems
Ambr process development platforms
Single-use bioprocess assemblies
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
VERIFIED ACTIVE 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Sartorius located?
Sartorius operates from Otto-Brenner-Strasse 20, 37079 Goettingen, Germany, Goettingen, Germany.
Who runs Sartorius?
Sartorius is led by Michael Grosse, Chief Executive Officer. Verified 14 Mar 2026.
What certifications does Sartorius hold?
Sartorius is documented under ISO 9001, ISO 13485, ISO 14001, ISO 50001.
What does Sartorius do?
Bioprocess infrastructure backbone with ISO 7/8 cleanroom production, single-use systems, and installed equipment across Baltic biologics manufacturing. Core capabilities: Single-use Bioprocess Equipment, Cell Culture Media, Process Analytics.
Editorial context

Related technical briefs

Briefs that name Goettingen as a covered market or city.